Institution Information
| Reportee | Signature Date | Report period | Total Entries | Total AUM($) |
|---|---|---|---|---|
| IKARIAN CAPITAL LLC | 02-14-2024 | 12-31-2023 | 136 | 1,067,984,222 |
Institutional Holdings
| Issuer | Class | Position | Value | Shares | Portfolio Percentage (%) | Previous Percentage (%) | Shares Delta | Shares Delta(%) | Date Reported |
|---|---|---|---|---|---|---|---|---|---|
| DYNE THERAPEUTICS INC | COM | 51 | $15,208,550 | 1,143,500 | 0.00 | 0.00 | 1,140,774 | 41847.91 | 12-31-2023 |
| SYNDAX PHARMACEUTICALS INC | COM | Liquidated | $0 | 0 | 0.00 | 14,000 | +Inf | 12-31-2023 | |
| REPLIMUNE GROUP INC | COM | Liquidated | $0 | 0 | 0.00 | 0.00 | -568,737 | -98.65 | 12-31-2023 |
| TARSUS PHARMACEUTICALS INC | COM | 54 | $12,525,010 | 618,519 | 0.00 | 0.00 | 100,000 | 19.29 | 12-31-2023 |
